GlassScriptPhysician profile
Scott R Short
NPI 1053460691
$313.82
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
See the full distribution for Pain Medicine (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $148 · 2020: $104 · 2021: $61.32.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $50.36 | 2020 | |
| Collegium Pharmaceutical, INC. | $42.57 | 2019 | |
| Scilex Pharmaceuticals INC. | $34.92 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $25.99 | 2021 | |
| Daiichi Sankyo INC. | $25.62 | 2019 | |
| Nevro Corp. | $20.18 | 2019 | |
| Redhill Biopharma INC. | $18.67 | 2020 | |
| Abbvie INC. | $18.17 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $17.56 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.50 | 2020 | |
| Boston Scientific Corporation | $17.16 | 2021 | |
| Assertio Therapeutics, INC. | $13.17 | 2019 | |
| Pfizer INC. | $11.95 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Short listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.